LHLynn D. Hudson

Lynn D. Hudson

*This is an algorithmically generated author record based on publicly available information.

Lynn D. Hudson has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Joseph A. Nielsen

    Section of Developmental Genetics, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, USA

    4 shared publications
  • Pierre Lau

    Section of Developmental Genetics, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA

    3 shared publications
  • Dragan Maric

    NINDS, NIH, Neurophysiology

    2 shared publications
  • Elena Romm

    Section of Developmental Genetics, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, USA

    2 shared publications
  • Jin G. Kim

    Section of Developmental Genetics, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

    2 shared publications
  • Joseph A. Nielsen

    Section of Developmental Genetics, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

    2 shared publications

Latest Publications

  • The genetics of oligodendrocytes

    by Joseph A. Nielsen, Pierre Lau, Lynn D. Hudson

    INTRODUCTION Over the past decade, there has been tremendous progress in our understanding of oligodendrocyte biology. Many of the factors that are important for the specification of oligodendrocytes during development have been identified (Kessaris et al., 2008). In addition, the emergence of genomic technologies has greatly improved our understanding of the factors that affect oligodendrocytes during development and in disease. In this chapter, we highlight some of the significant discoveries that have advanced our understanding of the genetic factors that are important in oligodendrocytes, and we identify some of the contributions that were made to this field using genomic technologies. OLIGODENDROCYTE SPECIFICATION A great deal of progress has been made in understanding the earliest events of oligodendrocyte specification. The spinal cord has received the most attention, and soluble signaling molecules such as sonic hedgehog (Shh) (Cai et al., 2005) and bone morphogenic proteins (BMPs) are key early regulators of oligodendrocyte development in this part of the central nervous system (CNS). Shh is secreted from the ventral floor plate and is required for the specification of oligodendrocytes (Orentas et al., 1999). Shh signaling induces the expression of the basic helix-loop-helix (bHLH) transcription factors Olig1 and Olig2 in a region of the ventral spinal cord referred to as the motor neuron progenitor (pMN) domain (Lu et al., 2000; Zhou et al., 2000). Shh and Olig gene expression is required for oligodendrocyte specification in the spinal cord and brain (Zhou and Anderson, 2002).

  • Open Access

    Integrating microRNA and mRNA expression profiles of neuronal progenitors to identify regulatory networks underlying the onset of cortical neurogenesis

    by Joseph A Nielsen, Pierre Lau, Dragan Maric, Jeffery L Barker, Lynn D Hudson

    Cortical development is a complex process that includes sequential generation of neuronal progenitors, which proliferate and migrate to form the stratified layers of the developing cortex. To identify the individual microRNAs (miRNAs) and mRNAs that may regulate the genetic network guiding the earliest phase of cortical development, the expression profiles of rat neuronal progenitors obtained at embryonic day 11 (E11), E12 and E13 were analyzed.


  • Open Access

    Identification of Dynamically Regulated MicroRNA and mRNA Networks in Developing Oligodendrocytes

    by Pierre Lau, Jonathan D. Verrier, Joseph A. Nielsen, Kory R. Johnson, Lucia Notterpek, Lynn D. Hudson

    MicroRNAs (miRNAs) play important roles in modulating gene expression at the posttranscriptional level. In postnatal oligodendrocyte lineage cells, the miRNA expression profile (“microRNAome”) contains 43 miRNAs whose expression dynamically changes during the transition from A2B5+oligodendrocyte progenitor cells to premyelinating GalC+cells. The combination of microRNAome profiling with analyses of the oligodendrocyte transcriptome reveals a target bias for a class of miRNAs which includes miR-9. We show that miR-9 is downregulated during oligodendrocyte differentiation. In addition, miR-9 expression level inversely correlates with the expression of its predicted targets, among which is the peripheral myelin protein PMP22. We found that PMP22 mRNA but not protein is detectable in oligodendrocytes, whereas Schwann cells producing PMP22 protein lack miR-9. We demonstrate that miR-9 interacts with the 3′ untranslated region of PMP22 and downregulates its expression. Our results support models in which miRNAs can act as guardians of the transcriptome.


  • Open Access

    The Genetic Signature of Perineuronal Oligodendrocytes

    by Sara Szuchet, Joseph Nielsen, Gabor Lovas, Javier Martinez de Velasco, Dragan Maric, Lynn Hudson

    Oligodendrocytes in the central nervous system can be categorized as precursors, myelin-forming, and non-myelinating perineuronal cells. The function of perineuronal oligodendrocytes is unknown; it was proposed that following injury, they may remyelinate denuded axons. We investigated these cells' potential. A combination of cell-specific tags, microarray technology and bioinformatics tools to identify gene expression differences between these subpopulations allowed us to capture the genetic signature of perineuronal oligodendrocytes. Here we report that perineuronal oligodendrocytes are configured for a dual role. As cells that embrace neuronal somata, they integrate a repertoire of transcripts designed to create their own code for communicating with neurons. But they maintain a reservoir of untranslated transcripts encoding the major myelin proteins for - we speculate - a demyelinating episode. We posit that the signature molecules, PDGFR-[alpha][beta] cytokine PDGF-CC, and transcription factor Pea3, used - among others - to define the non-myelinating phenotype, may be critical for mounting a myelinating programme during demyelination. Harnessing this capability is of therapeutic value for diseases such as multiple sclerosis. This is the first molecular characterization of an elusive neural cell.

  • Open Access

    Identification of a Novel Oligodendrocyte Cell Adhesion Protein Using Gene Expression Profiling

    by Joseph A. Nielsen, Dragan Maric, Pierre Lau, Jeffery L. Barker, Lynn D. Hudson

    Oligodendrocytes undergo extensive changes as they differentiate from progenitors into myelinating cells. To better understand the molecular mechanisms underlying this transformation, we performed a comparative analysis using gene expression profiling of A2B5+oligodendrocyte progenitors and O4+oligodendrocytes. Cells were sort-purifiedex vivofrom postnatal rat brain using flow cytometry. Using Affymetrix microarrays, 1707 transcripts were identified with a more than twofold increase in expression in O4+oligodendrocytes. Many genes required for oligodendrocyte differentiation were upregulated in O4+oligodendrocytes, including numerous genes encoding myelin proteins. Transcriptional changes included genes required for cell adhesion, actin cytoskeleton regulation, and fatty acid and cholesterol biosynthesis. At the O4+stage, there was an increase in expression of a novel proline-rich transmembrane protein (Prmp). Localized to the plasma membrane, Prmp displays adhesive properties that may be important for linking the extracellular matrix to the actin cytoskeleton. Together, our results highlight the usefulness of this discovery-driven experimental strategy to identify genes relevant to oligodendrocyte differentiation and myelination.


  • Open Access

    Myt1 family recruits histone deacetylase to regulate neural transcription

    by Elena Romm, Joseph A. Nielsen, Jin G. Kim, Lynn D. Hudson

    The myelin transcription factor 1 (Myt1) gene family is comprised of three zinc finger genes [Myt1, Myt1L (Myt1‐Like) and NZF3] of the structurally unique CCHHC class that are expressed predominantly in the developing CNS. To understand the mechanism by which this family regulates neural differentiation, we searched for interaction partners. In both yeast and a mammalian two‐hybrid system, Myt1 and Myt1L interacted with Sin3B, a protein that mediates transcriptional repression by binding to histone deacetylases (HDACs). Myt1–Sin3B complexes were co‐immunoprecipitated from transfected mammalian cells and included HDAC1 and HDAC2. Myt1 and Myt1L could partner with all three Sin3B isoforms, the long form (Sin3BLF) that includes the HDAC‐binding domain, and the two short forms (Sin3BSF293 and Sin3BSF302) that lack this domain and may consequently antagonize Sin3BLF/HDAC‐mediated co‐repression. Myt1 or Myt1L interactions with the HDAC‐binding form of Sin3B conferred repression on a heterologous promoter. Oligodendrocytes were shown to express transcripts encoding each of the Sin3B isoforms. We present a model in which the Myt1 family of zinc finger proteins, when bound to a neural promoter, can recruit Sin3B. Depending on the relative availability of Sin3B isoforms, the Myt1 gene family may favor the silencing of genes during neural development.


  • Control of myelin gene expression

    by Lynn D. Hudson, Nerissa Ko, Jin G. Kim

    This chapter focuses on the most recent efforts on the transcription front to unravel the means by which glial cells achieve their wraps. It begins with an overview of the coordinate control of myelin genes. It then addresses the following questions: which transcription factors are the players in myelinating cells? How does thyroid hormone impact the oligodendrocyte lineage? What about post-transcriptional controls in myelinating cells?